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TrlE presence of androgen receptors on synovial
macrophages in human normal and rheumatoid synovial
tissues has been described previously. It is now reported
that primary cultured human macrophages obtained
from normal and rheumatoid synovia express functional
androgen receptors. We have investigated the capacity of
cultured macrophages to metabolize androgens and have
found that these cells were capable of metabolizing
testosterone to the bioactive metaboHte dihydro-
testosterone. Therefore, macrophages contain the key
enzymes of steroidogenesis, in particular the 50t-
reductase. Furthermore, interleukin-l production by
primary cultured rheumatoid macrophages was analysed,
following exposure to physiological concentrations of
testosterone (10
-8 M). A significant decrease of IL-I lev-
els in conditioned media after 24 h (p < 0.05) was ob-
served. It is concluded that androgens may act directlyon
human macrophages and may interfere with some of
their functions via receptor-dependent mechanisms.
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Introduction
A sex-related dimorphism in immune capabilities is
thought to be related to the physiological effects of
sex hormones on the immune system. 1-5 Generally, at
least at physiological concentrations, oestrogens ex-
ert immunostimulatory effects, whereas androgens
are immunosuppressive and a preponderance of
autoimmune diseases in females compared with
males is well recognized. In rheumatoid arthritis
(RA), the synovial tissue is widely infiltrated by
mononuclear cells and is considered the target tissue
for a ’sexual dimorphism’ in the immune response.
2-7
Sex hormones seem to play a role in
immunomodulation via receptor-mediated mecha-
nisms.
High affinity androgen receptors (AR) have already
been detected in human maturing thymocytes.
-11
However, it is only recently that androgen and oes-
trogen receptors have been detected in synovial
macrophages (mCs) of normal and rheumatoid
synovial tissues, by immunostaining of cryosections
and by biochemical characterization in homogenized
tissues. 12,13 The presence of androgen receptors on
mCs induced us to analyse the metabolic pathway for
androgens.
MCs were found to be capable of effectively
metabolizing testosterone (Tes) to the bioactive
dihydrotestosterone (DHT). In addition, since
interleukin-l[3 (IL-113) is mainly synthesized by
activated macrophages and mediates the T- and
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B-lymphocyte stimulation during the immune re-
sponse, we investigated the influence of androgens
on IL-I production by using cultured RA mCs. It was
found that physiological concentrations of
testosterone (10-8 M) significantly decreased IL-l[3
content in conditioned media.
In conclusion we proved that human mCs express
functional androgen receptors and should be modu-
lated at least in some of their immune-related func-
tions (i.e. IL-I]3 production) by the sex hormones that
they actively metabolize.
Materials and Methods
Reagents: Anti-androgen receptor mAbs that are
known to react to human androgen and that do not
cross-react with other receptors or with
glucocorticoid receptors, were purchased from
BioReagents (Neshanic Station, NJ, USA). Anti-
macrophage associated antigens, Ber-MAC3 and
MAC387 mAbs were obtained from Dakopatts (Co-
penhagen, Denmark). Tritiated testosterone and
tritiated mibolerone were obtained from Amersham
(Buckinghamshire, UK). IL-113 solid phase enzyme
immunoassay (EIA) was obtained from Medgenix
Diagnostics (Fleurus, Belgium). Biotin-streptavidin-
amplified detection system was purchased from
BioGenex Laboratories (San Ramon, CA, USA) and
collagenase was from Sigma Chemical Co. (St Louis,
mo, USA).
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Preparation of synovial tissue samples and
synoviocyte culture.. Synovial tissue samples were
obtained from six women (mean age 49.6 _+ 14 years)
and six men (mean age 53.7 + 15 years) who fulfilled
the American College of Rheumatology criteria for
adult RA and were undergoing arthroscopic
synovectomy of the knee. 14 Synovial samples from
age and sex-matched subjects undergoing diagnostic
arthroscopy for recent trauma of the knee (<10 days)
were used as controls. 15 All the RA patients were
found to be affected by Steinbrocker class II RA. At
the time of surgery all the patients were being treated
exclusively with nonsteroidal anti-inflammatory
drugs. None had received any oral or intraarticular
corticosteroid therapy and slow-acting antirheumatic
drugs during the 4 months preceding the investiga-
tion, nor was the use of the oral contraceptive
pill, 1,25-dihydroxyvitamin D3 or any hormone
replacement therapy referred by the patients.1-18
All subjects had normal liver, renal, prostate and
thyroid functions and were within 20% of ideal body
weight.
Freshly obtained tissue samples from the synovial
lining were placed on ice, and stored at-20C in 30%
sucrose-50% glycerol buffer (v/v) (0.25 M sucrose, 10
mM HEPES and 1.5 mM MgCl2, pH 7.4) until analysis
for sex hormone receptors. Under these conditions,
the concentration and molecular form of the receptor
have been shown to be stable for at least 3 months. 19
At least four further samples collected from each
subject and from different areas of the synovial
tissue, were immediately snap-frozen in liquid nitro-
gen, cryoprotected with OCT (Miles, Noperville, IL,
USA) and stored at -90C until used for
immunohistopathological studies. Another series of
synovial tissue samples was used on the same day for
cell cultures. The synovial tissue was dissected away
from fatty, capsular components, cut into 3-5 mm
pieces, washed in Hanks’ balanced salt solution and
incubated in collagenase (1 mg/ml) for 3 h at 37C
with constant agitation. The digest was then passed
through a wire mesh with a pore size of 200 l.tm to
separate dissociated cells from tissue debris. The cells
were washed twice in collagenase and counted. The
mean cell yield was 4.9 x 106 (range 0.53-16.8 x 106)
and the mean viability was 88% (range: 69-98%). The
cells were then cultured with RPMI supplemented
with 10% FCS at 37C in humidified 5% CO2 in air.
After 3 h nonadherent cells were removed and the
adherent cells were cultured with RPMI supple-
mented with 10% FCS at 37C in humidified 5% CO2
in air for 72 h. The adherent population was subse-
quently stained for macrophage-specific antigens
(see immunostaining section) and was found to be
>80% ms. Every 24 h cytocentrifuge preparations
(800 x g for 3 min) of suspended cells (gentle scrap-
ing) were obtained and stored at-80C until
immunostaining.
Immunostaining of synovial cryosections and cul-
turedsynovial macrophages: Fivem thick cryostatic
sections (Cryocut 1800, Reichter-Jung, Leika,
Nussloch bei Heidelberg, Germany) of RA and con-
trol synovia as well as cytocentrifuge preparations of
cultured adherent synoviocytes, were mounted on
glass slides, air dried, and fixed in cold 95% acetone
for 10 min. A number of slides were incubated for
1 h with a rat anti-androgen receptor mAb (IgG) that
also recognizes the DNA-binding sequence of the
receptor (1:100).2 After two washes with phosphate
buffered saline, the second step was performed
using the improved biotin-streptavidin-amplified de-
tection system. Briefly, staining of anti-androgen re-
ceptor mAb, was carried out using the second-step
concentrated link antibody (biotinylated anti-Ig spe-
cific respectively for mouse and rat primary antibod-
ies) and the concentrated enzyme label (horseradish
peroxidase-conjugated streptavidin). The same slides
were treated a second time, with mAbs directed
towards single different macrophage-associated anti-
gens Ber-MAC3 (1:70) and MAC387 (1:70), then with
the second-step concentrated link antibody and
finally with the concentrated enzyme label (alkaline
phosphatase). Control slides were treated in an iden-
tical manner except that the first step was replaced by
nonspecific mouse or rat antibodies. The samples
were therefore examined by using a Leitz microscope
equipped with an epifluorescence system.
Steroid metabolism experiments: Methodological ap-
proaches and procedures used to measure metabolic
pathways of steroids have been previously estab-
lished and optimized.
2 Adherent synoviocytes (see
synoviocyte culture) were harvested by mild
trypsinization, counted in a haemocytometer and
plated onto 6-well tissue culture plates at a density of
0.5-1 x 106 cells/dish. After 24 h, cells were washed
twice with PBS-A and the medium substituted with
FCS-free, phenol red free RPMI medium, containing
10
-8 M tritiated Tes as precursor. Controls were
treated with FCS-free and phenol red free RPMI
medium alone. Following 24 h incubation, medium
was transferred to sterile plastic tubes (Costar) and
stored at- 80C until analysis; cells were washed
three times using PBS-A and solubilized in 3 ml of
0.1% SDS at 37C for 15-30 min. Aliquots (100 t.tl) of
the cell lysates were therefore used to estimate DNA
content, as described elsewhere.
22
Steroid extraction was carried out using 1 ml of
medium with 10 ml of dimethyl ether for androgens.
After mixing at 4C for 30 min, the resulting aqueous
phase was freeze-dried in a Speed Vac evaporator-
concentrator (Savant Instruments Inc., Farmingdale,
NY, USA) and then resuspended using 970 l.tl of
acetate buffer (0.75 M, pH 5.0) and 30 l-tl of Glusulase
enzyme mixture (DuPont Co., Wilmington, DE). The
solution was incubated at 37C for 18 h
to hydrolyse steroid conjugates (sulphates and
Mediators of Inflammation Vol 4 1995 139M. Cutolo et al.
glucuronides). The ether phase was evaporated to
dryness under nitrogen and then stored at- 20C
until required for analysis using reverse phase (RP)-
HPLC. The HPLC system consisted of a model 324
system, equipped with a model 160 UV detector set
at 280 nm (Beckman Instruments Inc., Berkeley, CA,
USA) and with ’on-line’ Flo-One/beta (model lC)
three channel radiometric detector (Radiomatic In-
struments, High Wycombe, Bucks, UK). Steroids
were separated under isocratic conditions using a
Spherisorb OS-11 (Aldrich Chimica, Milan, Italy) col-
umn (250 x 4.6 mmi.d.) and either 40% or 45%
acetonitrile in citric acid (0.05 M) as optimized mobile
phases for oestrogen and androgen separation re-
spectively, with a flow rate of i ml/min. Routine data
integration was automatically achieved and com-
puted in net cpm by a Flo-One/beta F1B program
(Radiomatic, Tampa, FL, USA).
IL-lfJ assay: Culture supernatants of RA ms. incu-
bated in the presence or absence of Tes, were har-
vested after 24 h and assessed for IL-I production.
IL-I concentrations in supernatants were measured
by specific solid phase enzyme immunoassay (EIA)
based on an oligoclonal system in which several
monoclonal antibodies directed against distinct
epitopes of IL-I[ are used. Briefly, a microtitre plate
precoated with several anti-IL-l[ monoclonal anti-
bodies was incubated, in duplicate, for 2 h at room
temperature, with 200 lal of standards (undiluted)
and synoviocyte culture supernatants (diluted 1:5
with a specific buffer solution) in the presence of a
different series of monoclonal anti-IL-l[ antibodies
labelled with horseradish peroxidase. A chromogen
(tetramethylbenzidine) was then added for 15 min
after washing to detect the enzyme activity, and the
reaction was then stopped by the addition of HaSO4.
The amount of substrate turnover, which is propor-
tional to the cytokine concentration, was determined
colorimetrically by measuring the absorbance using
a computerized reader (Vmax EASIA reader,
Medgenix). Concentrations as low as 2 pg/ml of IL-
1 are detectable with this assay. Cross-reaction with
other cytokines including IL-10t, TNF and interferons
have been reported to be insignificant. The intra-
assay coefficient of variation was 7% for IL-I.
Statistical analysis: Differences between samples
were analysed by Student’s t-test.
Results
Immunostaining of tissue cryosections and cultured
cells: The ms on synovial cryosections were double,.
labelled after double-immunostaining with the
Ber-MAC3 mAb and anti-androgen receptor mAbs,
respectively. Both a strong nuclear reaction for the
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hormone receptors and diffuse staining for the
phagocytic cell antigens (Ber-MAC3), including the
branched cytoplasmic extensions, were observed.
This effect is indicated by the arrows in Fig. I(A). The
mean percentage of sex hormone receptor positive
ms within the synovial lining was approximately
31-+ 10% in the rheumatoid synovia and 13 + 6% in
controls, by counting up to 200 cells in each area of
the tissue examined. Ms were present in a smaller
percentage in the sublining of all cryosection sam-
ples (about 65-70% less when compared with the
lining).
When double-immunostaining was performed us-
ing cytocentrifuge preparations of cultured ms, and
the same mAbs, an intense staining was confirmed
for the AR (Fig. I(B)). After staining for macrophage-
specific antigens (Ber-MAC3 and MAC-387) over 90%
of the cells from centrifuge preparations were found
to be ms.
Metabolism of sex hormones in vitro by short-term
cultured human synovial macrophages: Short-term
primary cultures ofRAms were exposed to approxi-
mately physiological concentrations of Tes (10-8 M)
for 24 h; tritiated Tes was added to the cell cultures
in order to evaluate the enzyme activity of these cells,
in restrictive culture conditions (i.e., without foetal
calf serum and in phenol red-free medium). Results
of these three experiments showed an appreciable
formation of dihydrotestosterone (DHT), the biologi-
cally active metabolite. Delta4-androstenedione (A4-
Ad) formation, even at relatively low levels, was also
detected (see Table 1). Experiments were carried out
in triplicate; the reproducibility was acceptable, as
revealed by the narrow standard deviation value, and
good extraction efficiency was obtained (> 90% in all
cases). Controls were negative for the presence of
androgens and their metabolites in the medium.
IL-I} production by cultured synovial macrophages:
To test whether testosterone modulates IL-I pro-
duction by cultured RA ms, the cells from five
separate RA donors were incubated for 24 h in the
presence of either medium alone (control cultures)
or medium supplemented with physiological con-
centrations of Tes (10
-8 M) (IL-I[ was assayed in the
supernatants by a specific EIA).
As shown in Fig. 2, Tes reduced the IL-I[ produc-
tion by cultured ms by a mean of 28% (range
12-57%) of control cultures. Although in the different
experiments the IL-I[ production varied widely in
control cultures, a significant difference in IL-I[
supernatant concentration was observed between
the Tes supplemented cultures when compared with
the controls (p 0.028; 95% confidence limits for
differences 43.8 and 560.4). A large difference in
basal IL-I[ concentrations was related to the differ-
ent clinical conditions of the RA donors evaluated.Androgens and macrophages in rheumatoid arthritis
FIG. 1. Human synovial macrophages (ms) after double-immunostaining with the anti-AR monoclonal antibody (mAb) and the anti-phagocytic cell antigen
antibody (Ber-MCA3) (cryosection, Panel A). Both a strong nuclear reaction for the AR; large arrows) and diffuse staining for the Ber-MAC3 (small arrows)
are present. Cultured ms after double-immunostaining with the same mAbs showed a similar pattern (cytocentrifuge preparation, Panel B; original
magnification x500).
Discussion
Previous studies have described androgen and
oestrogen receptors on whole synovial tissues from
healthy and RA patients and have identified the ms
among the positive cells. 12,13 Here we show that
primary cultures ofms isolated from human normal
and rheumatoid synovial tissues of both sexes ex-
2,000
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1,000-
500
[] -testosterone
[] +testosterone
0
2 3 4 5
Experiment no.
FIG. 2. Testosterone influence on IL-I production by cultured human
macrophages. Macrophages (1 10-) from five separate primary cultures
were cultured in ml of medium without (-) or with (+) testosterone for
24 h. Supernatants have been assayed by specific solid phase enzyme
immunoassay (EIA).
press functional androgen receptors. The
immunostaining with specific mAbs of the
cytocentrifuge preparations of primary cultured ms
confirmed intense staining for AR. The cells appear
also to contain the key enzymes of steroidogenesis,
as shown by their capability to form, in the short
term, the active metabolites of testosterone. In par-
ticular the results of the study indicate that ms are
endowed of 5x-reductase enzymes, the latter form-
ing DHT, the more biologically active metabolite, in
relatively short-term exposure (24 h).
In cultured ms the rate of conversion of Tes into
active metabolic products (i.e., DHT) was found very
close to that observed in classical target cells for
androgen activity such as human prostate cancer
cells (the conversion rate was 1.4% and 1.8%, respec-
tively). 23’24 Furthermore, DHT levels were found in
physiologically relevant amounts (0.56 pmol/100 btg
DNA or 7.54 x 10-1 M) as usually observed in classi-
cal target cells for peripheral androgen metabolism
(i.e., human prostate cancer cells). 24
Finally, since interleukin-1 is mainly synthesized
by activated macrophages and mediates lymphocyte
stimulation during immune response, it was found
that testosterone treatment (10-8 M) of cultured RA
ms, significantly decreased IL-I[ production at least
at the protein level, after 24 h. Further studies on IL-
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Table 1. Levels of free androgens, precursor and other products at
24 h in media of human cultured RA synovial macrophages
Precursor Tes DHT A4-Ad
[aH]-Tes *37.56 + 0.54 *0.56 + 0.02 "1.76 + 0.03
(5.12 x 10-9 M) (7.54 x 10-11 M) (2.36 x 10-10 M)
*Values (pmol/100.g DNA) are expressed as mean + S.D.
of three experiments in triplicate. In brackets values
expressed as molar concentrations.
Cells (1 x 106 were incubated for 24 h with 1.0 x 10.6 M of
[1,2,6,7-[aH](N)]-Tes (specific activity, 92.1 Ci/mmol) in FCS
and phenol red free RPMI medium.
(Tes Testosterone, DHT dihydrotestosterone, A4-Ad
Delta4 androstenedione).
I mRNA response are in progress. This inhibitory
effect by androgens on macrophage IL- production,
was found in cultured RAms obtained from patients
of both sexes, therefore indicating that the effect is
not sex-linked.
At the same physiological concentration (10-8 M)
employed in this assay, it is known that Tes
translocates androgen receptors to cell nuclei with-
out affecting other steroid receptors (i.e., oestrogen,
progesterone) or stimulating cell growth. 25 Further-
more, recent studies, have shown that even pharma-
cological concentrations of Tes (10-
M) inhibited IL-
1[ secretion by peripheral blood mononuclear cells
obtained from RA patients.
26
In contrast a dose-dependent influence of
oestradiol (E2) on IL-I[ production by human pe-
ripheral monocytes has been described. 27 In particu-
lar, physiological concentrations of E2 (10-8 or 10-9
M) seem to increase and pharmacological (10-5 M)
concentrations seem to inhibit IL-I[ secretion. Simi-
lar results have been also obtained in primary cul-
tures of RA ms (Cutolo, unpublished observations).
In all these experiments, the effect of androgens on
IL-I[ production by monocyte/macrophages was not
found to be sex-linked. In fact, physiological serum
androgen concentrations, as observed in basal con-
ditions in male subjects, may well decrease/inhibit
the synthesis of IL-I when monocyte/macrophages
are activated by different stimula.
An immunosuppressive activity exerted by andro-
gens is well assessed. Therefore the lower immune
response observed in males, can also explain the
reduced incidence of autoimmunity such as ob-
served in Systemic lupus erythematosus (SLE) or in
RA, in which females show a much higher suscepti-
bility. In addition, as known, male patients affected
by autoimmune diseases have been found to present
low serum levels of androgens when compared with
age-matched controls. 26
A sex hormone relationship is well assessed with
the different F:M ratios observed in various ages of
women and men affected by RA (a lower RA inci-
dence in men during fertile ages and a higher inci-
dence in elderly men; whereas the opposite situation
occurs in women). 28 Interestingly, a higher incidence
of immuno-mediated diseases such as SLE, second-
ary Sj6gren syndrome (SS) or RA is present in men
with Klinefelter’s syndrome more frequently than in
normal men. Klinefelter’s men are characterized by
high oestrogen and low androgen levels. 29 Further-
more low androgens, at least in male RA patients,
may be a genetically determined precursor rather
than a consequence of the disease, as shown by its
frequent association with the HLA antigen B15 even
in healthy male controls.3,31
All these observations may represent the basis for
the effectiveness of androgen replacement therapy in
RA as well as in Klinefelter’s patients.
29,32 Recently the
administration of dehydroepiandrosterone (DHEA),
an adrenal hormone with mild intrinsic androgenic
activity, has been reported to improve the disease
activity in SLE patients.3
In conclusion, androgens may at least partially
exert their immunosuppressive activity by acting on
human activated ms through respective receptor-
mediated mechanisms.4 These findings underscore
the importance of sex hormones in immune system
regulation and consequently confirm that both an-
drogen and oestrogen imbalance may have signifi-
cant implications in autoimmunity.35-8
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